The choice of antihypertensive drugs in patients with erectile dysfunction

Current Medical Research and Opinion

Volumn 18, Issue 2, 2002, Pages 103-107

  Khan, Masood A ^a   Morgan, Robert J ^a   Mikhailidis, Dimitri P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Angiotensin II; Antihypertensives; Doxazosin; Erectile dysfunction; Hypertension; Losartan

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; DOXAZOSIN; LOSARTAN; PROSTAGLANDIN DERIVATIVE; SILDENAFIL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; COST CONTROL; DRUG CHOICE; DRUG EFFECT; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; INCIDENCE; MALE; PATIENT COMPLIANCE; SHORT SURVEY;

AGED; ANTIHYPERTENSIVE AGENTS; DIABETES COMPLICATIONS; DOXAZOSIN; HUMANS; HYPERTENSION; IMPOTENCE; INSULIN RESISTANCE; LOSARTAN; MALE; MIDDLE AGED;

EID: 0036253918     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079902125000426     Document Type: Short Survey

References (35)

1. Corpora cavernosa ultrastructure in vascular erectile dysfunction
2. The microarchitecture of the intracavernosal smooth muscle and the cavernosal fibrous skeleton
3. Hypertension and impotence
4. Hypertension, stress and erectile dysfunction: Potential insights from the analysis of heart rate variability
5. Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men
6. Cigarette smoking and other vascular risk factors in vasculogenic impotence
7. Cigarette smoking, hypertension and erectile dysfunction
8. Diabetes, hypertension and erectile dysfunction
9. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study
10. The treatment of hypertension in patients with erectile dysfunction
11. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women
12. Fibrinogen, lipoprotein(a) and lipids in patients with erectile dysfunction: A preliminary study
13. The role of prostaglandins in the aetiology and treatment of erectile dysfunction
14. Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease?
15. Normal and pathological erectile function: The potential clinical role of endothelin-1 antagonists
16. The molecular basis of penile erection
17. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction
18. A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia
19. High prevalence of benign prostatic hypertrophy in the community
20. Sexual function in 131 patients with benign prostatic hyperplasia before prostatectomy
21. Benign prostatic hyperplasia and erectile dysfunction - Is there a link?
22. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
23. Diuretics vs α-blocker for the treatment of hypertension. Lessons from ALLHAT
24. Sexual dysfunction in hypertensive patients treated with losartan
25. The anatomy, physiology and molecular pathways of vascular erectile dysfunction
26. Hypertension, vascular disease and erectile dysfunction: Consensus statement
27. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension
28. Treating dyslipidaemia in non-insulin dependent diabetes mellitus - A special reference to statins
29. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
30. Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction
31. Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction
32. Sildenafil: A urologist's view
33. Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy
34. Erectile dysfunction: Intracavernous treatment
35. Cardiovascular effects of oral pharmacotherapy in erectile dysfunction